Inventiva S.A.(IVA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $17.5M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
IVA Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Inventiva S.A. (IVA), a Healthcare sector company. IVA is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $17.5m in revenue. Top institutional holders of IVA by reported 13-F value include Samsara BioCapital,, Caligan Partners, Paradigm Biocapital Advisors, based on the most recent SEC filings. IVA trades on the Nasdaq exchange and files with the SEC under CIK 1756594. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IVA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Inventiva S.A. directly from SEC EDGAR.
AI Insight: IVA Financial Trends
Data too sparse to identify meaningful financial trends across the reporting periods.
• No revenue, income, or cash flow data available for trend analysis.
⚠ Lack of financial disclosure limits visibility into operational performance and capital structure.
AI Insight: IVA Ratio Trends
No financial ratio data available for Inventiva S.A. across all periods, preventing trend analysis.
• All profitability and efficiency ratios show no data from Q4 2020 through Q2 2025.
⚠ Complete absence of ratio data suggests potential data reporting issues or early-stage operations.
Get alerted when IVA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Inventiva S.A. including:
Top Institutional Holders of IVA
Samsara BioCapital, LLC
$28.8M5,194,805 shCaligan Partners LP
$27.6M4,974,906 shParadigm Biocapital Advisors LP
$22.2M4,000,000 shMILLENNIUM MANAGEMENT LLC
$16.6M2,987,613 shTrails Edge Capital Partners, LP
$14.8M2,657,997 shFRANKLIN RESOURCES INC
$13.7M2,461,565 shSymBiosis Capital Partners, LLC
$13.1M2,354,000 shUBS Group AG
$12.9M2,318,693 shADAR1 Capital Management, LLC
$12.1M2,174,398 shPolar Capital Holdings Plc
$11.8M2,132,138 sh
| Fund | Value | Shares |
|---|---|---|
| Samsara BioCapital, LLC | $28.8M | 5,194,805 |
| Caligan Partners LP | $27.6M | 4,974,906 |
| Paradigm Biocapital Advisors LP | $22.2M | 4,000,000 |
| MILLENNIUM MANAGEMENT LLC | $16.6M | 2,987,613 |
| Trails Edge Capital Partners, LP | $14.8M | 2,657,997 |
| FRANKLIN RESOURCES INC | $13.7M | 2,461,565 |
| SymBiosis Capital Partners, LLC | $13.1M | 2,354,000 |
| UBS Group AG | $12.9M | 2,318,693 |
| ADAR1 Capital Management, LLC | $12.1M | 2,174,398 |
| Polar Capital Holdings Plc | $11.8M | 2,132,138 |
More Healthcare Companies
View all Healthcare →Put IVA on your watchlist
Track score changes the day Inventiva S.A. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is IVA a good stock to buy?
13F Pro's AI-powered analysis of Inventiva S.A. (IVA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IVA are available on the IVA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own IVA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IVA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Inventiva S.A.'s investment landscape.